查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2069645

標準注射筆針市場：依產品類型、針頭長度、針頭規格、治療應用、最終用戶、分銷管道、患者類型和相容性類型 - 市場規模、產業動態、機會分析及預測（2026-2035年）

Standard Pen Needles Market: By Product Type, Needle Length, Needle Gauge, Therapy Application, End User, Distribution Channel, Patient Type, Compatibility Type - Market Size, Industry Dynamics, Opportunity Analysis And Forecast For 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

標準注射筆針市場是全球醫療設備業中快速成長的細分市場，反映出慢性病管理中對注射給藥系統的依賴性日益增強。2025年，該市場規模約18億美元，預計2035年將達到約40.3億美元。該成長意味著2026年至2035年預測期間的年複合成長率（CAGR）為8.40%，顯示全球醫療保健系統的結構性因素支撐著持續的需求。

推動市場成長的主要因素是全球慢性病（尤其是糖尿病）盛行率的上升。糖尿病需要持續且往往終身的注射治療。隨著全球糖尿病確診人數的持續增加，對可靠且易於使用的注射裝置的需求也顯著成長。標準胰島素筆針在實現每日胰島素注射方面發揮著非常重要的作用，是糖尿病管理方案不可或缺的一部分。這些疾病的慢性特性確保了持續穩定的市場需求，為製造商提供了長期穩定的市場和可預測的成長模式。

顯著的市場趨勢

在標準注射筆針市場競爭格局中，主要參與者扮演著決定性角色，少數幾家全球製造商佔據了大部分的生產、分銷和技術進步。Becton, Dickinson and Company憑藉其廣泛的全球分銷網路和在醫療設備領域長期穩固的地位，在該行業中佔據主導地位。

Novo Nordisk將其專有的藥物輸送系統與廣泛的藥品組合相結合，在市場上也扮演關鍵角色。 Ypsomed Holding AG 以其對精密工程和持續產品創新的專注而聞名。 Owen Mumford 透過提供經濟高效且可靠的注射解決方案，在醫療機構和零售醫療場所中保持著強大的市場地位。

HTL-STREFA憑藉其大規模的生產能力，在大批量生產領域佔據主導地位。該公司著重醫療耗材的大量生產，高效地向全球醫療系統供應注射筆針頭及相關產品。這些主要企業憑藉著規模優勢、創新能力、與醫藥生態系統的整合以及成本競爭力，共同塑造了標準注射筆針頭市場的格局。

關鍵成長要素

全球疾病流行情況對醫療設備製造商的企業發展發揮非常重要的作用，也是推動市場擴張的最強勁的長期驅動力之一。隨著慢性病負擔的持續加重，已開發經濟體和新興經濟體的醫療保健系統都面臨著提供擴充性、高效且易於獲取的治療方案的持續壓力。疾病發生率的上升直接導致醫療設備終端使用者群體的擴大，尤其是那些用於長期治療和自我給藥療法的醫療器材。

新機會的趨勢

數位醫療的融合正成為推動注射給藥生態系統（包括筆式注射器和相關糖尿病護理設備）未來發展的關鍵趨勢。隨著醫療保健系統日益向資料驅動和以患者為中心的模式轉型，數位技術與傳統給藥工具的融合改變慢性病的管理方式。智慧互聯解決方案正整合到注射系統及相關平台中，以改善治療監測、加強臨床監管並幫助改善長期健康結果。

最佳化障礙

主要供應鏈瓶頸持續對標準筆式注射器市場的製造商造成重大影響，導致其難以維持不間斷生產並確保及時的全球分銷。儘管由於糖尿病等慢性疾病的日益普遍，筆式注射器的需求依然強勁，但全球採購、物流和製造基礎設施的脆弱性卻經常限制供應鏈的正常運作。這些中斷可能導致產品供應延遲、營運成本增加，甚至整個醫療設備供應鏈效率低。

目錄

第1章 執行摘要：全球標準注射筆針市場

第2章 調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：依地區分類
  • 本研究的前提
  • 市場規模估算
  • 資料三角測量

第3章 全球標準注射筆針市場概覽

  • 產業價值鏈分析
  • 產業展望
    • 全球注射給藥和糖尿病護理行業概覽
    • 糖尿病盛行率上升和GLP-1/肥胖治療的蓬勃發展
    • 過渡到較短的針頭和較注重安全性的裝置
  • PESTLE分析
  • 波特五力分析
  • 市場成長及前景
    • 2020-2035年市場收入估算與預測
    • 價格趨勢分析：依產品類型

第4章 全球標準注射筆針市場分析

  • 競爭儀錶板
    • 市場集中度
    • 企業市場占有率分析，2025年
    • 競爭對手分析與基準測試

第5章 全球標準注射筆針市場分析

  • 市場動態和趨勢
    • 成長促進因素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測，2020-2035年
    • 依產品類型
      • 關鍵見解
        • 標準筆針
        • 安全筆針
    • 依針長
      • 關鍵見解
        • 4 mm注射筆針
        • 5 mm注射筆針
        • 6 mm注射筆針
        • 8 mm注射筆針
        • 大於8 mm注射筆針
    • 依針規
      • 關鍵見解
        • 29G～30G
        • 31G～32G
        • 33G 以上
    • 依治療用途
      • 關鍵見解
        • 糖尿病管理
        • GLP-1 和肥胖管理
        • 生長激素荷爾蒙療法
        • 不孕症治療
        • 荷爾蒙補充療法
        • 其他注射療法
    • 依最終用戶
      • 關鍵見解
        • 醫院
        • 診所
        • 居家照護環境
        • 門診部
    • 依通路
      • 關鍵見解
        • 醫院藥房
        • 零售藥房
        • 網路藥房
        • 機構和批量採購管道
    • 依患者類型
      • 關鍵見解
        • 兒童患者
        • 成年患者
        • 老年患者
    • 依類型相容
      • 關鍵見解
        • 通用相容筆針
        • 依品牌分類的筆針
    • 依地區
      • 關鍵見解
        • 北美洲
          • 美國
          • 加拿大
          • 墨西哥
        • 歐洲
          • 西歐
            • 英國
            • 德國
            • 法國
            • 義大利
            • 西班牙
            • 其他西歐國家
          • 東歐
            • 波蘭
            • 俄羅斯
            • 其他東歐國家
        • 亞太地區
          • 中國
          • 印度
          • 日本
          • 澳洲和紐西蘭
          • 韓國
          • ASEAN
          • 其他亞太國家
        • 中東和非洲（MEA）
          • 沙烏地阿拉伯
          • 南非
          • UAE
          • 其他中東和非洲國家
        • 南美洲
          • 阿根廷
          • 巴西
          • 其他南美國家

第6章 北美市場分析

第7章 歐洲市場分析

第8章 亞太市場分析

第9章 中東和非洲市場分析

第10章 南美市場分析

第11章 公司簡介

  • Allison Medical, Inc.
  • Braun SE
  • Cardinal Health
  • Embecta Corp.
  • Medline Industries, LP.
  • MTD Medical Technology and Devices
  • Neon Diagnostics Limited
  • Owen Mumford
  • UltiMed, Inc.
  • 其他主要公司

第12章 附錄

簡介目錄
Product Code: AA06261823

The standard pen needles market represents a rapidly expanding segment within the global medical devices industry, reflecting the increasing reliance on injectable drug delivery systems for chronic disease management. In 2025, the market is valued at approximately USD 1.80 billion, and it is projected to reach around USD 4.03 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 8.40% during the forecast period from 2026 to 2035, highlighting sustained and structurally driven demand across global healthcare systems.

A primary driver of this market growth is the rising global prevalence of chronic diseases, especially diabetes, which requires continuous and often lifelong injectable treatment. As the number of patients diagnosed with diabetes continues to increase worldwide, demand for reliable and easy-to-use injection devices has expanded significantly. Standard pen needles play a crucial role in enabling daily insulin administration, making them an essential component of diabetes management protocols. The chronic nature of these conditions ensures consistent, recurring demand, which supports long-term market stability and predictable growth patterns for manufacturers.

Noteworthy Market Developments

Dominant players play a decisive role in shaping the competitive landscape of the standard pen needles market, with a relatively concentrated group of global manufacturers accounting for a significant share of production, distribution, and technological advancement. Becton, Dickinson and Company holds a leading position in the industry, supported by its extensive global distribution infrastructure and long-established presence in the medical device sector.

Novo Nordisk also plays a significant role in the market by integrating proprietary drug delivery systems with its broader pharmaceutical portfolio. Ypsomed Holding AG is recognized for its focus on precision engineering and continuous product innovation. Owen Mumford maintains a strong presence in the market by offering cost-effective and reliable injection solutions tailored to both institutional and retail healthcare settings.

HTL-STREFA leverages large-scale production capabilities to dominate the high-volume segment of the market. The company specializes in manufacturing medical consumables at scale, enabling it to efficiently supply pen needles and related products to global healthcare systems. Together, these dominant companies define the structure of the standard pen needles market through a combination of scale, innovation, integration with pharmaceutical ecosystems, and cost competitiveness.

Core Growth Drivers

Global disease prevalence plays a foundational role in shaping the commercial trajectory of medical device manufacturers, acting as one of the most powerful long-term drivers of market expansion. As the global burden of chronic illnesses continues to rise, healthcare systems across both developed and emerging economies are experiencing sustained pressure to provide scalable, efficient, and accessible treatment solutions. This rising disease incidence directly translates into an expanding end-user base for medical devices, particularly those used in long-term and self-administered therapies.

Emerging Opportunity Trends

Digital health integration is emerging as a significant opportunity trend driving the future growth of the injectable drug delivery ecosystem, including pen needles and associated diabetes care devices. As healthcare systems increasingly shift toward data-driven and patient-centric models, the integration of digital technologies with traditional drug delivery tools is transforming how chronic diseases are managed. Smart connectivity solutions are being embedded into injection systems and companion platforms to improve treatment monitoring, enhance clinical oversight, and support better long-term health outcomes.

Barriers to Optimization

Key supply chain bottlenecks continue to significantly impact manufacturers operating in the standard pen needles market, creating persistent challenges in ensuring uninterrupted production and timely global distribution. Although demand for pen needles remains structurally strong due to the rising prevalence of chronic diseases such as diabetes, the supply side is periodically constrained by vulnerabilities in global sourcing, logistics, and manufacturing infrastructure. These disruptions can lead to delays in product availability, increased operational costs, and inefficiencies across the broader medical device supply chain.

Detailed Market Segmentation

By product type, standard pen needles account for the larger share of the global market, reflecting their widespread use across both developed and emerging healthcare systems. These conventional configurations continue to dominate overall consumption volumes due to their established availability, broad compatibility with most insulin delivery pens, and long-standing presence in clinical practice. Their design simplicity and functional reliability have made them a default choice in routine therapeutic applications, particularly in large-scale chronic disease management such as diabetes care.

By needle length, 4 mm and 5 mm pen needles dominate the global market, primarily due to their strong clinical performance and improved patient acceptance. These shorter needle formats have become the preferred standard in modern injectable drug delivery because they significantly enhance comfort during administration while maintaining reliable therapeutic efficacy. Their widespread adoption reflects a broader shift in clinical practice toward minimizing treatment burden, particularly for patients requiring long-term or daily self-injections, such as those managing diabetes and other chronic metabolic conditions.

By needle gauge, the 29G-30G segment dominates the market due to its optimal balance between patient comfort and functional performance in subcutaneous drug delivery. These ultra-fine gauges are widely preferred in clinical practice because they significantly reduce injection pain while still maintaining sufficient structural strength for safe and reliable administration. Manufacturers have optimized these needle sizes to ensure that they provide an effective compromise between minimal tissue trauma and adequate durability, making them highly suitable for repeated daily use, particularly in chronic disease management applications such as diabetes care.

By therapy application, diabetes management represents the largest and most influential segment in the global market, driven by the persistent and widespread need for injectable treatment solutions. Diabetes, particularly Type 1 and insulin-dependent Type 2 cases, is characterized by a long-term disruption in the body's ability to regulate blood glucose levels, making external insulin administration a critical and often lifelong requirement. For a significant portion of patients, insulin therapy is not optional but medically essential, as it replaces or supplements the body's insufficient natural insulin production. This creates a continuous and non-discretionary demand for injection-based drug delivery systems, positioning diabetes care as the core application area supporting sustained market growth.

Segment Breakdown

By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Needle Length

  • 4 mm Pen Needles
  • 5 mm Pen Needles
  • 6 mm Pen Needles
  • 8 mm Pen Needles
  • Above 8 mm Pen Needles

By Needle Gauge

  • 29G-30G
  • 31G-32G
  • 33G and Above

By Therapy Application

  • Diabetes Management
  • GLP-1 & Obesity Management
  • Growth Hormone Therapy
  • Fertility Treatment
  • Hormone Replacement Therapy
  • Other Injectable Therapies

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Care Centers

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Institutional & Bulk Procurement Channels

By Patient Type

  • Pediatric Patients
  • Adult Patients
  • Geriatric Patients

By Compatibility Type

  • Universal-Compatible Pen Needles
  • Brand-Specific Pen Needles

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America held a dominant position in the standard pen needles market in 2025, supported by its highly developed healthcare infrastructure, strong purchasing power, and widespread adoption of injectable drug delivery systems. The region's leadership is primarily anchored by the United States, which accounts for the largest share of demand due to its extensive patient base requiring chronic disease management and its advanced clinical ecosystem.
  • The United States in particular has established clear regional dominance through its unmatched healthcare spending levels and high rates of clinical diagnosis for chronic conditions. The country's healthcare system supports early detection and continuous management of long-term diseases, which in turn drives sustained demand for injectable therapies and associated delivery devices.
  • A key factor supporting this market expansion is the structure of the American commercial insurance framework, which effectively absorbs a significant portion of the financial burden associated with chronic disease management. This allows patients to maintain consistent access to prescription-based injectable treatments without major financial barriers.

Leading Market Participants

  • Allison Medical, Inc.
  • Braun SE
  • Cardinal Health
  • Embecta Corp.
  • Medline Industries, LP.
  • MTD Medical Technology and Devices
  • Neon Diagnostics Limited
  • Owen Mumford
  • UltiMed, Inc.
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Standard Pen Needles Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Standard Pen Needles Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers (Medical-Grade Stainless Steel, Polymers)
    • 3.1.2. Pen Needle Manufacturers
    • 3.1.3. Sterilization & Quality Assurance Providers
    • 3.1.4. Distribution Channels (Hospital, Retail, Online Pharmacies)
    • 3.1.5. Healthcare Providers & Patients (Diabetes, GLP-1 / Obesity Therapy)
  • 3.2. Industry Outlook
    • 3.2.1. Overview of the Global Injectable Drug Delivery & Diabetes Care Industry
    • 3.2.2. Rising Diabetes Prevalence & GLP-1 / Obesity Therapy Boom
    • 3.2.3. Shift Toward Shorter Needles & Safety-Engineered Devices
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Product Type

Chapter 4. Global Standard Pen Needles Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Standard Pen Needles Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Standard Pen Needles
        • 5.2.1.1.2. Safety Pen Needles
    • 5.2.2. By Needle Length
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. 4 mm Pen Needles
        • 5.2.2.1.2. 5 mm Pen Needles
        • 5.2.2.1.3. 6 mm Pen Needles
        • 5.2.2.1.4. 8 mm Pen Needles
        • 5.2.2.1.5. Above 8 mm Pen Needles
    • 5.2.3. By Needle Gauge
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. 29G-30G
        • 5.2.3.1.2. 31G-32G
        • 5.2.3.1.3. 33G and Above
    • 5.2.4. By Therapy Application
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Diabetes Management
        • 5.2.4.1.2. GLP-1 & Obesity Management
        • 5.2.4.1.3. Growth Hormone Therapy
        • 5.2.4.1.4. Fertility Treatment
        • 5.2.4.1.5. Hormone Replacement Therapy
        • 5.2.4.1.6. Other Injectable Therapies
    • 5.2.5. By End User
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Hospitals
        • 5.2.5.1.2. Clinics
        • 5.2.5.1.3. Homecare Settings
        • 5.2.5.1.4. Ambulatory Care Centers
    • 5.2.6. By Distribution Channel
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. Hospital Pharmacies
        • 5.2.6.1.2. Retail Pharmacies
        • 5.2.6.1.3. Online Pharmacies
        • 5.2.6.1.4. Institutional & Bulk Procurement Channels
    • 5.2.7. By Patient Type
      • 5.2.7.1. Key Insights
        • 5.2.7.1.1. Pediatric Patients
        • 5.2.7.1.2. Adult Patients
        • 5.2.7.1.3. Geriatric Patients
    • 5.2.8. By Compatibility Type
      • 5.2.8.1. Key Insights
        • 5.2.8.1.1. Universal-Compatible Pen Needles
        • 5.2.8.1.2. Brand-Specific Pen Needles
    • 5.2.9. By Region
      • 5.2.9.1. Key Insights
        • 5.2.9.1.1. North America
          • 5.2.9.1.1.1. The U.S.
          • 5.2.9.1.1.2. Canada
          • 5.2.9.1.1.3. Mexico
        • 5.2.9.1.2. Europe
          • 5.2.9.1.2.1. Western Europe
            • 5.2.9.1.2.1.1. The UK
            • 5.2.9.1.2.1.2. Germany
            • 5.2.9.1.2.1.3. France
            • 5.2.9.1.2.1.4. Italy
            • 5.2.9.1.2.1.5. Spain
            • 5.2.9.1.2.1.6. Rest of Western Europe
          • 5.2.9.1.2.2. Eastern Europe
            • 5.2.9.1.2.2.1. Poland
            • 5.2.9.1.2.2.2. Russia
            • 5.2.9.1.2.2.3. Rest of Eastern Europe
        • 5.2.9.1.3. Asia Pacific
          • 5.2.9.1.3.1. China
          • 5.2.9.1.3.2. India
          • 5.2.9.1.3.3. Japan
          • 5.2.9.1.3.4. Australia & New Zealand
          • 5.2.9.1.3.5. South Korea
          • 5.2.9.1.3.6. ASEAN
          • 5.2.9.1.3.7. Rest of Asia Pacific
        • 5.2.9.1.4. Middle East & Africa (MEA)
          • 5.2.9.1.4.1. Saudi Arabia
          • 5.2.9.1.4.2. South Africa
          • 5.2.9.1.4.3. UAE
          • 5.2.9.1.4.4. Rest of MEA
        • 5.2.9.1.5. South America
          • 5.2.9.1.5.1. Argentina
          • 5.2.9.1.5.2. Brazil
          • 5.2.9.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Product Type
      • 6.2.1.2. By Needle Length
      • 6.2.1.3. By Needle Gauge
      • 6.2.1.4. By Therapy Application
      • 6.2.1.5. By End User
      • 6.2.1.6. By Distribution Channel
      • 6.2.1.7. By Patient Type
      • 6.2.1.8. By Compatibility Type
      • 6.2.1.9. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Product Type
      • 7.2.1.2. By Needle Length
      • 7.2.1.3. By Needle Gauge
      • 7.2.1.4. By Therapy Application
      • 7.2.1.5. By End User
      • 7.2.1.6. By Distribution Channel
      • 7.2.1.7. By Patient Type
      • 7.2.1.8. By Compatibility Type
      • 7.2.1.9. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Product Type
      • 8.2.1.2. By Needle Length
      • 8.2.1.3. By Needle Gauge
      • 8.2.1.4. By Therapy Application
      • 8.2.1.5. By End User
      • 8.2.1.6. By Distribution Channel
      • 8.2.1.7. By Patient Type
      • 8.2.1.8. By Compatibility Type
      • 8.2.1.9. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Product Type
      • 9.2.1.2. By Needle Length
      • 9.2.1.3. By Needle Gauge
      • 9.2.1.4. By Therapy Application
      • 9.2.1.5. By End User
      • 9.2.1.6. By Distribution Channel
      • 9.2.1.7. By Patient Type
      • 9.2.1.8. By Compatibility Type
      • 9.2.1.9. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Product Type
      • 10.2.1.2. By Needle Length
      • 10.2.1.3. By Needle Gauge
      • 10.2.1.4. By Therapy Application
      • 10.2.1.5. By End User
      • 10.2.1.6. By Distribution Channel
      • 10.2.1.7. By Patient Type
      • 10.2.1.8. By Compatibility Type
      • 10.2.1.9. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. Allison Medical, Inc.
  • 11.2. Braun SE
  • 11.3. Cardinal Health
  • 11.4. Embecta Corp.
  • 11.5. Medline Industries, LP.
  • 11.6. MTD Medical Technology and Devices
  • 11.7. Neon Diagnostics Limited
  • 11.8. Owen Mumford
  • 11.9. UltiMed, Inc.
  • 11.10. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators